Rating date
Jun 2, 2026
69 days ago
EMR Equity Research — HOLD — June 2026
Rating date
Jun 2, 2026
69 days ago
Desk view
HOLD
5D move
-2.08%
Neutral (HOLD unscored)
Peer rank
67p
Research history
2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 moreInvestment card · EMR
From June 2025 through early June 2026, EMR traced a steady upward path. The stock opened the window at ~$117 (June 2, 2025) and ground higher through mid-2025, reaching the $130s by August and consolidating in a $124–$132 range through ...
Desk rating
HOLD
Tactical HOLD · 12M OW
Horizon
Tactical HOLD · 12M OVERWEIGHT
Confidence
Medium
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Bias
HOLD
Catalysts
Risks
Price context alongside the research narrative.
Full desk note for Jun 2, 2026. Use tabs for catalysts, valuation and risks, or open the full note.
WebserviceX · Agentic Research Desk
EMR bias
HOLD
Horizon
Tactical HOLD · 12M OVERWEIGHT
EMR key risk
Event-driven repricing risk if expectations diverge from incoming evidence.
EMR catalyst watch
Bullish long-term trend remains intact — EMR has traded above its rising 200-day SMA for the entire window, and the golden cross (50 > 200 SMA) is firmly established.
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Confidence
Medium
How the call aged · 5D
Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-09T07:21:35.967261+00:00.
5D move
-2.08%
2026-06-02 → 2026-06-08
Outcome
Neutral (HOLD unscored)
5D trend
+0.75%
Vol (20D ann.)
+37.86%
vs SPY: -0.44%
Close 142.03 → — (USD, vendor closes)
Publish QC
Pipeline fingerprint 781c0b04aa680fac
No QC issues recorded.